These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 20531244)
1. Alterations in gene expression in MEN1-associated insulinoma development. Serewko-Auret MM; Mould AW; Loffler KA; Duncan R; Kay GF; Hayward NK Pancreas; 2010 Nov; 39(8):1140-6. PubMed ID: 20531244 [TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis. Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767 [TBL] [Abstract][Full Text] [Related]
3. Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor. Lejonklou MH; Barbu A; Stålberg P; Skogseid B Endocrinology; 2012 Jun; 153(6):2588-98. PubMed ID: 22492302 [TBL] [Abstract][Full Text] [Related]
4. Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability. Scacheri PC; Kennedy AL; Chin K; Miller MT; Hodgson JG; Gray JW; Marx SJ; Spiegel AM; Collins FS Cancer Res; 2004 Oct; 64(19):7039-44. PubMed ID: 15466197 [TBL] [Abstract][Full Text] [Related]
5. Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Bertolino P; Tong WM; Herrera PL; Casse H; Zhang CX; Wang ZQ Cancer Res; 2003 Aug; 63(16):4836-41. PubMed ID: 12941803 [TBL] [Abstract][Full Text] [Related]
6. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases. Corbo V; Dalai I; Scardoni M; Barbi S; Beghelli S; Bersani S; Albarello L; Doglioni C; Schott C; Capelli P; Chilosi M; Boninsegna L; Becker KF; Falconi M; Scarpa A Endocr Relat Cancer; 2010 Sep; 17(3):771-83. PubMed ID: 20566584 [TBL] [Abstract][Full Text] [Related]
7. Neurogenin 3 and neurogenic differentiation 1 are retained in the cytoplasm of multiple endocrine neoplasia type 1 islet and pancreatic endocrine tumor cells. Lejonklou MH; Edfeldt K; Johansson TA; Stålberg P; Skogseid B Pancreas; 2009 Apr; 38(3):259-66. PubMed ID: 19307926 [TBL] [Abstract][Full Text] [Related]
8. [The role and mechanism of high expression of cyclin B2 in MEN1 insulinoma]. Wu T; Huang XH Sheng Li Xue Bao; 2011 Dec; 63(6):555-64. PubMed ID: 22193451 [TBL] [Abstract][Full Text] [Related]
9. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Crabtree JS; Scacheri PC; Ward JM; Garrett-Beal L; Emmert-Buck MR; Edgemon KA; Lorang D; Libutti SK; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1118-23. PubMed ID: 11158604 [TBL] [Abstract][Full Text] [Related]
10. The Cell Death Inhibitor ARC Is Induced in a Tissue-Specific Manner by Deletion of the Tumor Suppressor Gene Men1, but Not Required for Tumor Development and Growth. McKimpson WM; Yuan Z; Zheng M; Crabtree JS; Libutti SK; Kitsis RN PLoS One; 2015; 10(12):e0145792. PubMed ID: 26709830 [TBL] [Abstract][Full Text] [Related]
11. Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays. Stålberg P; Santesson M; Ekeblad S; Lejonklou MH; Skogseid B Surgery; 2006 Dec; 140(6):921-9; discussion 929-31. PubMed ID: 17188139 [TBL] [Abstract][Full Text] [Related]
12. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells. Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834 [TBL] [Abstract][Full Text] [Related]
13. Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development. Lu J; Herrera PL; Carreira C; Bonnavion R; Seigne C; Calender A; Bertolino P; Zhang CX Gastroenterology; 2010 May; 138(5):1954-65. PubMed ID: 20138042 [TBL] [Abstract][Full Text] [Related]
18. MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1. Jiang XH; Lu JL; Cui B; Zhao YJ; Wang WQ; Liu JM; Fang WQ; Cao YN; Ge Y; Zhang CX; Casse H; Li XY; Ning G Endocr Relat Cancer; 2007 Dec; 14(4):1073-9. PubMed ID: 18045958 [TBL] [Abstract][Full Text] [Related]
19. MEN1 missense mutations impair sensitization to apoptosis induced by wild-type menin in endocrine pancreatic tumor cells. Bazzi W; Renon M; Vercherat C; Hamze Z; Lacheretz-Bernigaud A; Wang H; Blanc M; Roche C; Calender A; Chayvialle JA; Scoazec JY; Cordier-Bussat M Gastroenterology; 2008 Nov; 135(5):1698-1709.e2. PubMed ID: 18775714 [TBL] [Abstract][Full Text] [Related]
20. The multiple endocrine neoplasia type 1 gene product, menin, inhibits insulin production in rat insulinoma cells. Sayo Y; Murao K; Imachi H; Cao WM; Sato M; Dobashi H; Wong NC; Ishida T Endocrinology; 2002 Jun; 143(6):2437-40. PubMed ID: 12021209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]